The Story
News Summary
- Motley Fool analysts reviewed Target's latest earnings beat and expanding digital delivery efforts against Amazon.
- They also evaluated Moderna's Phase 3 cancer vaccine milestone alongside signs of decelerating revenue growth and deepening operational losses at OpenAI amid an intensifying AI market race.
Explore AMZN price history & advisor snapshot
These are separate market snapshots and may predate this story. Check the data period, generation time and expiry before using them in your research.
Stored market data
AMZN price history
248.31
+8.36% over the displayed period
Advisor Snapshot
Unlock Member-Only Insights
Reserved for TradingNews24 members. Log in or create a free account to access market signals and exclusive tools.